PRKAA1 and Insulin resistance: Pharmacological AMPK activators, such as 5-aminoimidazole-4-carboxamide (AICA) riboside, ameliorate insulin resistance in rodent models5,17,18, although poor bioavailability limits their biological effects in vivo.